Induced pluripotent stem cells: History, properties and potential applications

Medical Journal of Malaysia

Volumn 66, Issue 1, 2011, Pages 4-9

  Nordin, N ^a,b   Lai, M I ^a,b   Veerakumarasivam, A ^a,b   Ramasamy, R ^a,b   Abdullah, S ^a,b   Wendy Yeo, W Y ^a   Rosli, R ^a,b  

^a UNIVERSITY PUTRA MALAYSIA   (Malaysia)

^b PERDANA UNIVERSITY   (Malaysia)

Author keywords

Epigenetics status; Induced pluripotent stem cells; Pluripotency markers; Reprogramming genes

Indexed keywords

ARTICLE; AUTOLOGOUS STEM CELL TRANSPLANTATION; CELL DIFFERENTIATION; CELL STRUCTURE; COPY NUMBER VARIATION; DISEASE MODEL; EMBRYONIC STEM CELL; EPIGENETICS; FANCONI ANEMIA; GENOMIC INSTABILITY; HISTORY; HUMAN; NONHUMAN; NONVIRAL GENE DELIVERY SYSTEM; NUCLEAR REPROGRAMMING; PARKINSON DISEASE; PLURIPOTENT STEM CELL; SINGLE NUCLEOTIDE POLYMORPHISM; SOMATIC CELL; STEM CELL EXPANSION; TOXICITY TESTING; VIRAL GENE DELIVERY SYSTEM; INDUCED PLURIPOTENT STEM CELL; REGENERATIVE MEDICINE;

HUMANS; INDUCED PLURIPOTENT STEM CELLS; REGENERATIVE MEDICINE;

EID: 79960166478     PISSN: 03005283     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (71)

1. Lensch M, Daheron L, Schlaeger T. Pluripotent stem cells and their niches. Stem Cell Rev 2006; 2(3): 185-201.
2. Guidelines for stem cell research and therapy, M.o.H.M. Medical Development Division, Editor. 2009: Kuala Lumpur. p. 70.
3. Martin M, Muotri A, Gage F, Varki A. Human embryonic stem cells express an immunogenic nonhuman sialic acid. Nat Med 2005; 11(2): 228-32.
4. Food and Drug Administration: PHS Guideline on Infectious Disease Issues in Xenotransplantation. Washington DC, Department of Health and Human Services. 2001; Available from: http://www.fda.gov/cber/gdlns/xenophs0101.htm.
5. Jensen J, Hyllner J, Björquist P. Human embryonic stem cell technologies and drug discoveries. J Cell Physiol 2009; 219(3): 513-9.
6. Fong CY, Gauthaman K, Bongso A. Teratomas from pluripotent stem cells: A clinical hurdle. J Cell Biochem 2010; 111(4): 769-81.
7. Nakajima F, Tokunaga K, Nakatsuji N. Human leukocyte antigen matching estimations in a hypothetical bank of human embryonic stem cell lines in the Japanese population for use in cell transplantation therapy. Stem Cells. 2007; 25(4): 983-5.
8. Condic ML, Rao M. Regulatory issues for personalized pluripotent cells. Stem Cells 2008; 26(11): 2753-8.
9. Osafune K, Caron L, Borowiak M, et al. Marked differences in differentiation propensity among human embryonic stem cell lines. Nat Biotechnol 2008; 26(3): 313-5.
10. Wakayama T, Tabar V, Rodriguez I, Perry A, Studer L, Mombaerts P. Differentiation of embryonic stem cell lines generated from adult somatic cells by nuclear transfer. Science 2001; 292(5517): 740-3.
11. Brambrink T, Hochedlinger K, Bell G, Jaenisch R. ES cells derived from cloned and fertilized blastocysts are transcriptionally and functionally indistinguishable. Proc Natl Acad Sci U S A 2006; 103(4): 933-8.
12. Takahashi K, Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 2006; 126(4): 663-76.
13. Marchetto M, Yeo G, Kainohana O, Marsala M, Gage F, Muotri A. Transcriptional signature and memory retention of human-induced pluripotent stem cells. PLoS ONE 2009; 4(9): e7076.
14. Okita K, Ichisaka T, Yamanaka S. Generation of germline-competent induced pluripotent stem cells. Nature 2007; 448(7151): 313-7.
15. Wernig M, Meissner A, Foreman R, et al. In vitro reprogramming of fibroblasts into a pluripotent ES-cell-like state. Nature 2007; 448(7151): 318-24.
16. Maherali N, Srihadran R, Xie W, et al. Directly reprogrammed fibroblasts show global epigenetic remodeling and widespread tissue contribution. Cell Stem Cell 2007; 1(1): 55-70.
17. Yu J, Vodyanik M, Smuga-Otto K, et al. Induced pluripotent stem cell lines derived from human somatic cells. Science 2007; 318(5858): 1917-20.
18. Takahashi K, Tanabe K, Ohnuki M, et al. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 2007; 131(5): 861-72.
19. Park I, Arora N, Huo H, et al. Disease-specific induced pluripotent stem cells. Cell 2008; 134(5): 877-86.
20. Zeuschner D, Mildner K, Zaehres H, Schöler H. Induced Pluripotent Stem Cells at Nanoscale. Stem Cells Dev 2010; 19(5): 615-20.
21. Amabile G, Meissner A. Induced pluripotent stem cells: current progress and potential for regenerative medicine. Trends Mol Med 2009; 15(2): 59-68.
22. Aasen T, Raya A, Barrero M, et al. Efficient and rapid generation of induced pluripotent stem cells from human keratinocyte. Nat Biotechnol 2008; 26(11): 1276-84.
23. Stadtfeld M, Brennand K, Hochedlinger K. Reprogramming of pancreatic beta cells into induced pluripotent stem cells. Curr Biol 2008; 18(12): 890-4.
24. Park I, Lerou P, Zhao R, Huo H, Daley G. Generation of human-induced pluripotent stem cells. Nat Protoc 2008; 3(7): 1180-6.
25. Cowan C, Klimanskaya I, McMahon J, et al. Derivation of embryonic stemcell lines from human blastocysts. N Engl J Med 2004; 350(13): 1353-56.
26. Zhou H, Wu S, Joo J, et al. Generation of induced pluripotent stem cells using recombinant proteins. Cell Stem Cell 2009; 4(5): 381-4.
27. Nakagawa M, Koyanagi M, Tanabe K, et al. Generation of induced pluripotent stem cells without Myc from mouse and human fibroblasts. Nat Biotechnol 2008; 26(1): 101-6.
28. Huangfu D, Osafune K, Maehr R, et al. Induction of pluripotent stem cells from primary human fibroblasts with only Oct4 and Sox2. Nat Biotechnol 2008; 26(11): 1269-75.
29. Mikkelsen T, Hanna J, Zhang X, et al. Dissection direct reprogramming through integrative genomix analysis. Nature 2008; 454(7200): 49-55.
30. Lowry W, Richter L, Yachechko R, et al. Generation of human induced pluripotent stem cells from dermal fibroblasts. Proc Natl Acad Sci U S A 2008; 105: 2883-88.
31. Mayshar Y, Ben-David U, Lavon N, et al. Identification and classification of chromosomal aberrations in human induced pluripotent stem cells. Cell Stem Cell. 2010;7(4): 521-31.
32. Laurent L, Wong E, Li G, et al. Dynamic changes in the human methylome during differentiation. Genome Res. 2010; 20(3): 320-31.
33. Pan G, Tian S, Nie J, et al. Whole-genome analysis of histone H3 lysine 4 and lysine 27 methylation in human embryonic stem cell. Cell Stem Cell 2007; 1(3): 299-312.
34. Das AK, Pal R. Induced pluripotent stem cells (iPSCs): the emergence of a new champion in stem cell technology-driven biomedical applications. J Tissue Eng Regen Med 2010; 4(6): 413-21.
35. Chambers S, Fasano C, Papapertrou E, Tomishima M, Sadelain M, Studer L. Highly efficient neural conversion of human ES and iPSCs by dual inhibition of SMAD signaling. Nat Biotechnol 2004; 27(3): 275-80.
36. Choi K, Yu J, Smuga-Otto K, et al. Hematopoietic and endothelial differentiation of human induced pluripotent stem cells. Stem Cells 2009; 27(3): 559-67.
37. Zhang D, Jiang W, Liu M, et al. Highly efficient differentiation of human ES cells and iPSCs into mature pancreatic indulin-producing cells. Cell Res 2009; 19(4): 429-38.
38. Song Z, Cai J, Liu Y, et al. Efficient generation of hepatocyte-like cells from human induced pluripotent stem cells. Cell Res 2009; 19(11): 1233-42.
39. Meyer J, Shearer R, Capowski E, et al. Modeling early retinal development with human embryonic and induced pluripotent stem cells. Proc Natl Acad Sci U S A 2009; 106(39): 16698-703.
40. Zhang J, Wilson G, Soerens A, et al. Functional cardiomyocytes derived from human induced pluripotent stem cells. Circ Res 2009; 104(4): e30-41.
41. Tanaka T, Tohyama S, Murata M, et al. In vitro pharmacologic testing using human induced pluripotent stem cell-derived cardiomyocytes. Biochem Biophys Res Commun Cell 2007; 385(4): 495-502.
42. Boland M, Hazen J, Nazor K, et al. Adult mice generated from induced pluripotent stem cells. Nature 2009; 461(7260): 91-4.
43. Kang L, Wang J, Zhang Y, Kou Z, Gao S. iPSCs can support full-term development of tetraploid blastocyst-complemented embryos. Cell Stem Cell 2009; 5(2): 135-8.
44. Zhao X, Li W, Lu Z, et al. iPSCs produce viable mice through tetraploid complementation. Nature 2009; 461(7260): 86-90.
45. Chakraborty C, Shah KD, Cao WG, Hsu CH, Wen ZH, Lin CS. Potentialities of induced pluripotent stem (iPS) cells for treatment of diseases. Curr Mol Med 2010; 10(8): 756-62.
46. Redon R, Ishikawa S, Fitch K, et al. Global variation in copy number in the human genome. Nature 2006; 444(7118): 444-54.
47. Lee G, Papapetrou E, Kim H, et al. Modelling pathogenesis and treatment of familial dysautonomia using patient-specific iPSCs. Nature 2009; 461(7262): 402-6.
48. Sullivan G, Hay D, Park I, et al. Generation of functional human hepatic endoderm from human induced pluripotent stem cells. Hepatology 2010; 51(1): 329-35.
49. Papadeas S, Maragakis N. Advances in stem cell research for Amyotrophic Lateral Sclerosis. Curr Opin Biotechnol 2009; 20(5): 545-51.
50. Li J, Gao G, Yuan T. Cell based vaccination using transplantation of iPSCderived memory B cells. Vaccine 2009; 27(42): 5728-9.
51. Hanna J, Wernig M, Markoulaki S, et al. Treatment of sickle cell anemia mouse model with iPSCs generated from autologous skin. Science 2007; 318(5858): 1920-3.
52. Wernig M, Zhao J, Pruszak J, et al. Neurons derived from reprogrammed fibroblasts functionally integrate into the fetal brain and improve symptoms of rats with Parkinson's disease. Proc Natl Acad Sci U S A 2008; 105(15): 5856-61.
53. Chin M, Mason M, Xie W, et al. Induced pluripotent stem cells ad embryonic stem cells are distinguished by gene expression signatures. Cell Stem Cell 2009; 5(1): 111-23.
54. Zhou W, Freed C. Adenoviral gene delivery can reprogram human fibroblasts to induced pluripotent stem cells. Stem Cells 2009; 27(11): 2667-74.
55. Huangfu D, Osafune K, Maehr R, et al. Induction of pluripotent stem cells from primary human fibroblasts with only Oct4 and Sox2. Nat Biotechnol 2008; 26(11): 1269-75.
56. Soldner F, Hockemeyer D, Beard C, et al. Parkinson's disease patient-derived induced pluripotent stem cells free of viral reprogramming factors. Cell 2009; 136(5): 964-77.
57. Kaji K, Norrby K, Paca A, Mileikovsky M, Mohseni P, Woltjen K. Virus-free induction of pluripotency and subsequent excision of reprogramming factors. Nature 2009; 458(7239): 771-5.
58. Woltjen K, Michael I, Mohseni P, et al. PiggyBac transposition reprograms fibroblasts to induced pluripotent stem cells. Nature 2009; 458(7239): 766-70.
59. Yu J, Hu K, Smuga-Otto K, et al. Human induced pluripotent stem cells free of vector and transgene sequences. Science 2009; 324(5928): 797-801.
60. Marson A, Foreman R, Chevalier B, et al. Wnt signaling promotes reprogramming of somatic cells to pluripotency. Cell Stem Cell 2008; 3(2): 132-5.
61. Page R, Ambady S, Holmes W, et al. Induction of stem cell gene expression in adult human fibroblasts without transgenes. Cloning Stem Cells 2009; 11(3): 417-26.
62. Aoi T, Yae K, Nakagawa M, et al. Generation of pluripotent stem cells from adult mouse liver and stomach cells. Science 2008; 321(5889): 699-702.
63. Kim J, Zaehres H, Wu G, et al. Pluripotent stem cells induced from adult neural stem cells by reprogramming with two factors. Nature 2008; 454(7204): 646-50.
64. Eminli S, Utikal J, Arnold K, Jaenisch R, Hochedlinger K. Reprogramming of neural progenitor cells into induced pluripotent stem cells in the absence of exogenous Sox2 expression. Stem Cells 2008; 26(10): 2467-74.
65. Hanna J, Markoulaki S, Schorderet P, et al. Direct reprogramming of terminally differentiated mature B lymphocytes to pluripotency. Cell 2008; 133(2): 250-64.
66. Loh Y, Agarwal S, Park I, et al. Generation of induced pluripotent stem cells from human blood. Blood 2009; 113(22): 5476-9.
67. Ye Z, Zhan H, Mali P, et al. Human-induced pluripotent stem cells from blood cells of healthy donors and patients with acquired blood disorders. Blood 2009;114(27): 5473-80.
68. Haase A, Olmer R, Schwanke K, et al. Generation of induced pluripotent stem cells from human cord blood. Cell Stem Cell 2009; 5(4): 434-41.
69. Giorgetti A, Montserrat N, Aasen T, et al. Generation of induced pluripotent stem cells from human cord blood using OCT4 and SOX2. Cell Stem Cell 2009; 5(4): 353-7.
70. Sun N, Panetta N, Gupta D, et al. Feeder-free derivation of induced pluripotent stem cells from adult human adipose stem cells. Proc Natl Acad Sci U S A 2009; 106(37): 15720-5.
71. Lai MI, Ramasamy R, Wendy WY, Nordin N, Rosli R, Veerakumarasivam A and Abdullah S. Advancements in Reprogramming Strategies for the Generation of Induced Pluripotent Stem Cells. Journal of Assisted Reproduction and Genetics. Doi: 10.1007/s10815-11-9552-6.